49 results
DEFA14A
AEON
AEON Biopharma Inc. - Ordinary Shares
14 May 24
Additional proxy soliciting materials
9:14am
to use its pre-change net operating loss carryforwards, or NOLs, and other pre-change tax attributes, such as research tax credits, to offset its post … ), the Company had $87.3 million and $67.5 million of federal NOLs available to offset our future federal taxable income, if any, and federal research
8-K/A
EX-99.8
pejwkiv8p9se26 v0
11 Aug 23
Financial Statements and Exhibits
9:12pm
8-K
EX-10.13
s4c xpa9xlc3r
27 Jul 23
Index to Financial Statements
5:28pm
8-K
EX-99.3
98c2xyh3g0
27 Jul 23
Index to Financial Statements
5:28pm
8-K
EX-10.12
e3gnkj
27 Jul 23
Index to Financial Statements
5:28pm